PT - JOURNAL ARTICLE AU - Muhammad Irfanur Rashid AU - Takuji Ito AU - Daisuke Shimojo AU - Kanae Arimoto AU - Kazunari Onodera AU - Rina Okada AU - Takunori Nagashima AU - Kazuki Yamamoto AU - Zohora Khatun AU - Hideyuki Okano AU - Hidetoshi Sakurai AU - Kazunori Shimizu AU - Manabu Doyu AU - Yohei Okada TI - Simple and efficient differentiation of human iPSCs into contractible skeletal muscles for muscular disease modeling AID - 10.1101/2021.11.22.468571 DP - 2021 Jan 01 TA - bioRxiv PG - 2021.11.22.468571 4099 - http://biorxiv.org/content/early/2021/11/22/2021.11.22.468571.short 4100 - http://biorxiv.org/content/early/2021/11/22/2021.11.22.468571.full AB - Pathophysiological analysis and drug discovery targeting human diseases require disease models that suitably recapitulate patients’ pathology. Disease-specific human induced pluripotent stem cells (hiPSCs) can potentially recapitulate disease pathology more accurately than existing disease models when differentiated into affected cell types. Thus, successful modeling of muscular diseases requires efficient differentiation of hiPSCs into skeletal muscles. hiPSCs transduced with doxycycline-inducible MYOD1 (MYOD1-hiPSCs) have been widely used; however, they require time- and labor-consuming clonal selection procedures, and clonal variations must be overcome. Moreover, their functionality to exhibit muscular contraction has never been reported. Here, we demonstrated that bulk MYOD1- hiPSCs established with puromycin selection, but not with G418 selection, showed high differentiation efficiency, generating more than 80% Myogenin (MyoG)+ and Myosin heavy chain (MHC)+ muscle cells within seven days. Interestingly, bulk MYOD1-hiPSCs exhibited average differentiation properties compared with those of clonally established MYOD1- hiPSCs, suggesting that the bulk method may minimize the effects of clonal variations. Finally, three-dimensional muscle tissues were fabricated from bulk MYOD1-hiPSCs, which exhibited contractile force upon electrical pulse stimulation, indicating their functionality. Together, the findings indicate that our bulk differentiation requires less time and labor than existing methods, efficiently generates contractible skeletal muscles, and facilitates the generation of muscular disease models.Competing Interest StatementHO is a paid member of the Scientific Advisory Board of SanBio Co., Ltd., and YO is a scientific advisor of Kohjin Bio Co., Ltd. The other authors declare no competing financial interests.